Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction.
Valentina StranieroVíctor Sebastián-PérezMartina Hrast RambaherCarlo ZanottoAndrea CasiraghiLorenzo SuigoIrena ZdovcAntonia RadaelliCarlo De Giuli MorghenErmanno ValotiPublished in: ChemMedChem (2019)
FtsZ is a crucial prokaryotic protein involved in bacterial cell replication. It recently arose as a promising target in the search for antimicrobial agents able to fight antimicrobial resistance. In this work, going on with our structure-activity relationship (SAR) study, we developed variously 7-substituted 1,4-benzodioxane compounds, linked to the 2,6-difluorobenzamide by a methylenoxy bridge. Compounds exhibit promising antibacterial activities not only against multidrug-resistant Staphylococcus aureus, but also on mutated Escherichia coli strains, thus enlarging their spectrum of action toward Gram-negative bacteria as well. Computational studies elucidated, through a validated FtsZ binding protocol, the structural features of new promising derivatives as FtsZ inhibitors.
Keyphrases
- antimicrobial resistance
- staphylococcus aureus
- escherichia coli
- multidrug resistant
- structure activity relationship
- biofilm formation
- case control
- silver nanoparticles
- klebsiella pneumoniae
- randomized controlled trial
- cell therapy
- anti inflammatory
- binding protein
- gram negative
- drug resistant
- protein protein
- amino acid
- mesenchymal stem cells
- bone marrow
- dna binding